Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes

This publication has 59 references indexed in Scilit:

• Flavin-containing monooxygenases: mutations, disease and drug response
  Trends in Pharmacological Sciences, 2008
• Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data
  BMJ, 2008
• Assessment of Endoplasmic Reticulum Glutathione Redox Status Is Confounded by Extensive Ex Vivo Oxidation
  Antioxidants & Redox Signaling, 2008
• Characterization of mouse flavin-containing monooxygenase transcript levels in lung and liver, and activity of expressed isoforms
  Biochemical Pharmacology, 2008
• EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets
  Antimicrobial Agents and Chemotherapy, 2007
• Mechanism of thioamide drug action against tuberculosis and leprosy
  Journal of Experimental Medicine, 2007
• Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients
  Antimicrobial Agents and Chemotherapy, 2006
• GENETIC POLYMORPHISMS OF FLAVIN-CONTAINING MONOOXYGENASE (FMO)
  Drug Metabolism Reviews, 2002
• Ethnic Differences in Human Flavin-Containing Monooxygenase 2 (FMO2) Polymorphisms: Detection of Expressed Protein in African-Americans
  Toxicology and Applied Pharmacology, 2000
• Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans
  Chemico-Biological Interactions, 1995